Shionogi & Co., Ltd. (4507.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥3,037 (-0.46%) as of
Key statistics
- Market cap
- 2.59T
- P/E (TTM)
- 9.81
- Forward P/E
- 15.88
- EPS (TTM)
- 309.57
- Dividend yield
- 2.49%
- 52-week range
- 2,432.00 – 3,758.00
- Beta
- 0.06
- Revenue (TTM)
- 563.21B
- Profit margin
- 46.79%
- Analyst target
- ¥3,354.55
- Volume
- 2.43M
About Shionogi & Co., Ltd.
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Kita, Japan
- Employees
- 6,223
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.